Kenta Yamamoto
Affiliations: | 2010-2015 | Pathology and Cell Biology | Columbia University College of Physicians and Surgeons, New York, NY, United States |
Google:
"Kenta Yamamoto"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Milanovic M, Houghton LM, Menolfi D, et al. (2020) The cancer-associated ATM R3008H mutation reveals the link between ATM activation and its exchange. Cancer Research |
| Yamamoto K, Wang J, Sprinzen L, et al. (2016) Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors. Elife. 5 |
| Yamamoto K, Wang J, Sprinzen L, et al. (2016) Author response: Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors Elife |
| Yamamoto K, Lee BJ, Li C, et al. (2015) Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice. Leukemia. 29: 1414-24 |
| Avagyan S, Churchill M, Yamamoto K, et al. (2014) Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency. Blood. 124: 1622-5 |
| Yamamoto K, Wang Y, Jiang W, et al. (2012) Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice. The Journal of Cell Biology. 198: 305-13 |
| Liu X, Jiang W, Dubois RL, et al. (2012) Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development. Proceedings of the National Academy of Sciences of the United States of America. 109: 3903-8 |